Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to oral cavity cancer
- 3 July 2002
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 38 (5) , 486-490
- https://doi.org/10.1016/s1368-8375(01)00086-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Genetic polymorphisms in head and neck cancer riskHead & Neck, 2000
- Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancersPharmacogenetics, 1998
- Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinomaCarcinogenesis: Integrative Cancer Research, 1996
- Human glutathione S-transferase μ (GSTμ) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokersCancer Letters, 1993
- PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 geneNucleic Acids Research, 1991
- The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended NomenclatureDNA and Cell Biology, 1991
- Glutathione S-transferase isoenzymes in human bronchoal veolar lavage: a possible early marker for the detection of lung cancerCarcinogenesis: Integrative Cancer Research, 1990
- Liver glutathione S-transferase polymorphism in Japanese and its pharmacogenetic importanceHuman Genetics, 1987
- A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancerCarcinogenesis: Integrative Cancer Research, 1986
- Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties.Proceedings of the National Academy of Sciences, 1985